Financial Times: Endless innovating when it comes to R&D policy can only be unhelpful
David Connell, Senior Research Associate at the Centre for Business Research at Cambridge Judge Business School, is mentioned in this article about the importance of innovation for business growth. Read the full article [ft.com]…
Research impact
Research & Development study by David Connell of the Centre for Business Research at Cambridge Judge Business School is cited by UK Chancellor of the Exchequer Rishi Sunak in a high-profile lecture. A study on lagging Research & Development (R&D)…
The Times: It’s a mistake to think all problems can be solved with extra investment
Further coverage of a report on the UK’s research and development tax credit scheme by David Connell, Senior Research Associate at the Centre for Business Research at Cambridge Judge Business School. The UK government’s flagship £7.3 billion-a-year tax credit scheme…
Financial Times: UK tax break failing to deliver extra R&D spending, study finds
A report on the UK’s research and development tax credit scheme by David Connell, Senior Research Associate at the Centre for Business Research at Cambridge Judge, covered in Financial Times. The UK government’s flagship £7.3 billion-a-year tax credit scheme for…
Industrial policy failure
The UK's £7.3 billion flagship research and development tax credit scheme is failing to stimulate the additional spending required to meet the Government's R&D target, concludes a new report from the Centre for Business Research at Cambridge Judge Business School.…
Forbes India: How drug companies can increase their R&D effectiveness
A study co-authored by Professor Stylianos Kavadias and Dr Nektarios Oraiopoulos at University of Cambridge Judge Business School, is featured in the Forbes article. The study demonstrates “how pharmaceutical executives can impact the success of their research and development” programs…
Why Arm’s sale to NVIDIA has stunned the tech industry
Hamza Mudassir, Visiting Fellow in Strategy and alumnus (MBA 2012) of Cambridge Judge Business School, discusses how Cambridge-based Arm's proposed sale to NVIDIA has stunned the tech industry. Hamza Muddasir Arm, the Cambridge-based microchip designer, is a British tech success…
Biotech vs big pharma
Most approved "priority" medicines are developed by biotech rather than large pharmaceutical firms, says a two-decade study at the University of Cambridge Judge Business School. Biotech companies created 40 per cent more US Food & Drug Administration-approved "priority" drugs than…
Small business jumpstart
Author of industrial strategy review of the UK Small Business Research Initiative calls for increased focus on customer-funded innovation contracts to allow founders to grow substantial UK firms. The author of a new independent review of the UK’s Small Business…
R&D a key element to rebalance the economy, says Cambridge study
Renewed UK government spending on innovative R&D can create new industries A renewed focus on innovative research and development spending by major UK departments would create new export-oriented industries and help rebalance the economy, says a new study published today…
